Safety and Risks of Topical Treatments
At a Glance
People with ichthyosis vulgaris have a weakened skin barrier that can increase absorption of topical medicines. Avoid salicylic acid in infants and young children unless a specialist prescribes it, and use acids, urea, steroids, and occlusive wraps only as directed.
While the daily management of Ichthyosis Vulgaris (IV) relies on topical treatments, the “leaky” nature of the skin barrier means that safety must be your first priority. In healthy skin, the barrier is a brick-and-mortar wall that keeps chemicals out. In IV, the lack of filaggrin means that wall has gaps, which can allow certain active ingredients to be absorbed more deeply into the body, especially when applied to large or damaged areas [1][2].
The Critical Warning: Salicylic Acid
A rare but serious safety risk for people with IV is the use of salicylic acid. While this is a common ingredient in many “rough and bumpy skin” lotions, it poses a documented risk of life-threatening toxicity—especially in infants and children [3][4].
Because the IV skin barrier is impaired, salicylic acid can be absorbed systemically (into the blood), leading to a condition called salicylism [3]. Cases have been reported where infants developed:
- Severe metabolic acidosis: A dangerous buildup of acid in the blood [3].
- Multiorgan dysfunction: Including liver and kidney stress [3].
- Altered mental status: Confusion, extreme sleepiness, or irritability [3].
Safety Rule: Do NOT use products containing salicylic acid on infants or young children with IV unless an appropriate specialist explicitly prescribes them. For adults, salicylic acid use requires individualized clinician advice; follow the label and dermatologist guidance while avoiding large-area, prolonged, or occluded use [4][5].
When to Seek Emergency Care
Toxicity is uncommon but very serious. If you or your child are using a product containing salicylic acid and notice any of the following, stop using the product immediately and contact a poison control center or emergency services:
- Rapid or heavy breathing (tachypnea) [4].
- Persistent vomiting or nausea [4].
- Ringing in the ears or dizziness.
- Unusual drowsiness or confusion [3].
Managing Irritation and Stinging
Even safer ingredients like urea and lactic acid can cause local side effects because of the impaired barrier.
Urea Tolerability
Low concentrations of urea (2% to 12%) are generally well-tolerated and can be used over large areas [6]. However, as the concentration increases (20% to 40%), the risk of side effects grows:
- Stinging and Burning: This is the most common complaint, especially when applied to skin that is red, inflamed, or has open cracks (fissures) [7][8].
- Penetration Enhancement: Urea not only hydrates but also makes the skin more permeable. If you apply a medicated cream (like a steroid) on top of a urea cream, your body may absorb more of that medication than intended [9][10]. While doctors sometimes use this combination intentionally, you should follow your prescriber’s instructions and avoid unsupervised layering.
Alpha-Hydroxy Acids (AHA)
Ingredients like lactic acid (ammonium lactate) and glycolic acid are effective but can be harsh.
- Avoid Broken Skin: Never apply these acids to bleeding, weeping, or infected skin [11]. The “stinging” you feel is a sign of nerve irritation and barrier breach.
- Sun Sensitivity: These acids thin the outer layer of dead skin, which can make you more susceptible to sunburn. Always use sun protection on treated areas.
The Risks of Occlusion (Wrapping)
“Occlusion” refers to covering a treated area with plastic wrap, tight clothing, or “wet wraps” to increase moisture. While this helps hydrate the skin, it also dramatically increases the absorption of whatever is underneath the wrap [5].
Never use high-concentration acids (like salicylic or glycolic acid) under an occlusive wrap unless specifically instructed by a dermatologist. This combination bypasses the skin’s remaining defenses and significantly increases the risk of both severe chemical burns and systemic toxicity [5]. For safe wrapping at home, avoid putting keratolytics or strong acids under a wrap without medical direction, and stick to plain emollients (like petrolatum) or ceramide creams [12].
Common questions in this guide
Is salicylic acid safe for a child with ichthyosis vulgaris?
What are the warning signs of salicylic acid toxicity?
Can urea cream cause stinging with ichthyosis vulgaris?
Can I apply a steroid cream over urea cream?
Should lactic acid or glycolic acid be used on cracked skin?
What can I put under a wet wrap for ichthyosis vulgaris?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my (or my child's) age and the amount of skin being treated, which over-the-counter ingredients are safe for daily use?
- 2.Is this specific moisturizer I'm using free of salicylic acid?
- 3.If I am prescribed a topical steroid and a urea cream, how should I sequence them to avoid excessive absorption?
- 4.Are there specific wet-wrap protocols you recommend for severe eczema flares, and which products belong under the wrap?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Revisiting the Roles of Filaggrin in Atopic Dermatitis.
Moosbrugger-Martinz V, Leprince C, Méchin MC, et al.
International journal of molecular sciences 2022; (23(10)) doi:10.3390/ijms23105318.
PMID: 35628125 - 2
Low Threshold for Cutaneous Allergen Sensitization but No Spontaneous Dermatitis or Atopy in FLG-Deficient Mice.
Muhandes L, Chapsa M, Pippel M, et al.
The Journal of investigative dermatology 2021; (141(11)):2611-2619.e2 doi:10.1016/j.jid.2021.02.763.
PMID: 33894197 - 3
Systemic Salicylate Toxicity From Topical Emollient Use in an Infant With Suspected Ichthyosis.
Pullukat K, Husien T
Cureus 2026; (18(6)):e110778 doi:10.7759/cureus.110778.
PMID: 42292717 - 4
Unmasking the Hidden Risk of Systemic Toxicity from Topical Salicylates.
Tabatabai N, Dash S, Chenoweth JA, Albertson TE
The western journal of emergency medicine 2025; (26(5)):1459-1467 doi:10.5811/westjem.46538.
PMID: 41193027 - 5
Characterizing local and systemic exposure to clobetasol propionate in healthy subjects and patients with atopic dermatitis.
Duong JK, van Dijkman S, Ong G, et al.
British journal of clinical pharmacology 2025; (91(11)):3150-3166 doi:10.1002/bcp.70102.
PMID: 40641358 - 6
Clinical evidences of urea at low concentration.
Lacarrubba F, Nasca MR, Puglisi DF, Micali G
International journal of clinical practice 2020; (74 Suppl 187()):e13626 doi:10.1111/ijcp.13626.
PMID: 33249706 - 7
The efficacy of topical treatments for acanthosis nigricans: a systematic review of randomized controlled trials.
Alamri A, Alraddadi RA, Alzahrani D, et al.
Frontiers in medicine 2025; (12()):1641322 doi:10.3389/fmed.2025.1641322.
PMID: 41140645 - 8
Chamomile Gel versus Urea Cream to Prevent Acute Radiation Dermatitis in Head and Neck Cancer Patients: Results from a Preliminary Clinical Trial.
Ferreira EB, Ciol MA, de Meneses AG, et al.
Integrative cancer therapies 2020; (19()):1534735420962174 doi:10.1177/1534735420962174.
PMID: 32985288 - 9
Urea: A Clinically Oriented Overview from Bench to Bedside.
Friedman AJ, von Grote EC, Meckfessel MH
Journal of drugs in dermatology : JDD 2016; (15(5)):633-9.
PMID: 27168272 - 10
Evaluation of 30% Urea Pretreatment in Enhancing the Efficacy of Photodynamic Therapy for Actinic Keratoses of the Scalp.
Arisi M, Crivellari M, Galli B, et al.
Dermatology practical & conceptual 2026; (16(2)) doi:10.5826/dpc.1602a6578.
PMID: 41910629 - 11
Use of Topical Glycolic Acid Plus a Lovastatin-Cholesterol Combination Cream for the Treatment of Autosomal Recessive Congenital Ichthyoses.
Khalil S, Bardawil T, Saade S, et al.
JAMA dermatology 2018; (154(11)):1320-1323 doi:10.1001/jamadermatol.2018.2904.
PMID: 30208477 - 12
Basic Emollients for Xerosis Cutis Not Associated With Atopic Dermatitis: A Review of Clinical Studies.
Szepietowski JC, Tadini G
International journal of dermatology 2025; (64 Suppl 1()):29-46 doi:10.1111/ijd.17794.
PMID: 40444760
This page explains potential risks of topical treatments for ichthyosis vulgaris for education only and is not medical advice. A dermatologist or other clinician should help choose products, especially for children, broken skin, or large treatment areas.
Get notified when new evidence is published on Ichthyosis vulgaris.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.